California Research Institute (Cri)

Los Angeles, California 90027-6005

0 studies enrolling now · 6 studies all time

What they study most

Metastatic Breast Cancer, Metastatic Colon Cancer, Metastatic Colorectal Cancer, Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis, Post Polycythemia Vera Myelofibrosis, Primary Myelofibrosis, Recurrent or Metastatic Breast Cancer

Studies at this site

• To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313) — Stopped early
• To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib (LIMBER-304) — Stopped early
• A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal Cancer — Completed
• Oral Paclitaxel Efficacy Safety and PK in Recurrent and Metastatic Breast Cancer — Completed
• Efficacy Evaluation of Enobosarm Monotherapy in Treatment of AR+/ER+/HER2- Metastatic Breast Cancer — Stopped early
• Efficacy Evaluation of Sabizabulin Monotherapy Versus Active Control for Treatment of ER+HER2- Metastatic Breast Cancer — Withdrawn before enrolling